Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT00593502
Eligibility Criteria:
Inclusion Criteria:
* Age 1-3 years
* Fever = or \> 38.0 C and at least one respiratory symptom OR fever = or \> 38.0 C and a positive influenza rapid test
Exclusion Criteria:
* Confirmed infection with any other respiratory virus than influenza.
* Suspicion of invasive bacterial infection requiring immediate admission to hospital
* Evidence of a poorly controlled underlying medical condition
* Known immunosuppression (malignancy, transplant, drugs)
* Known allergy to oseltamivir or paracetamol
* Received oseltamivir within 4 weeks
* Participation in another clinical trial with an investigational drug
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
3 Years
Study:
NCT00593502
Study Brief:
Protocol Section:
NCT00593502